PKN Antibody Blocking peptide

Serine/threonine-protein kinase N1, Protease-activated kinase 1, PAK-1, Protein kinase C-like 1, Protein kinase C-like PKN, Protein kinase PKN-alpha, Protein-kinase C-related kinase 1, Serine-threonine protein kinase N, PKN1, PAK1, PKN, PRK1, PRKCL1

The synthetic peptide sequence was selected from the C-term region of human PKN . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.